What does CUSIP 50127T109 represent in this 13F holders report?

CUSIP 50127T109 is the security identifier for KURA - Kura Oncology, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held KURA - Kura Oncology, Inc. - Common Stock in Q1 2021?

162 institutional investors reported KURA - Kura Oncology, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Kura Oncology, Inc. - Common Stock (KURA)

CUSIP: 50127T109

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 87,054,674
Total 13F shares: 68,584,982
Share change: +4,168,035
Total reported value: $1,942,401,972
Put/Call ratio: 1.3%
Price per share: $28.27
Number of holders: 162
Value change: +$106,818,236
Number of buys: 80
Number of sells: 86

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 50127T109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	10%	9,116,040	$297,730,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	5.7%	4,931,956	$161,079,000	—	31 Dec 2020	13F
Avoro Capital Advisors LLC	13F	Company	4.6%	4,000,000	$130,640,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	3.7%	3,232,932	$105,587,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	3.5%	3,067,613	$100,189,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	3.1%	2,677,220	$87,438,000	—	31 Dec 2020	13F
Foresite Capital Management IV, LLC	13F	Company	2.1%	1,807,982	$59,049,000	—	31 Dec 2020	13F
EcoR1 Capital, LLC	13F	Company	2%	1,773,037	$57,907,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	2%	1,701,781	$55,580,000	—	31 Dec 2020	13F
Holocene Advisors, LP	13F	Company	1.9%	1,619,546	$52,894,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.8%	1,530,250	$49,978,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.5%	1,336,829	$43,661,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.4%	1,255,297	$40,998,000	—	31 Dec 2020	13F
BVF INC/IL	13F	Company	1.4%	1,245,912	$40,691,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.2%	1,060,000	$34,620,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.2%	1,057,665	$34,544,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	1.2%	1,050,289	$34,302,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	995,491	$32,512,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	1.1%	929,282	$30,351,000	—	31 Dec 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.91%	789,964	$25,799,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.86%	751,263	$24,536,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.84%	731,869	$23,903,000	—	31 Dec 2020	13F
Cormorant Asset Management, LP	13F	Company	0.75%	650,000	$21,229,000	—	31 Dec 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.75%	650,000	$21,229,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.74%	648,510	$21,183,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.74%	643,124	$21,004,000	—	31 Dec 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.73%	637,500	$20,821,000	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	0.69%	600,000	$19,596,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.67%	583,916	$19,071,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.67%	580,593	$18,962,000	—	31 Dec 2020	13F
VR Adviser, LLC	13F	Company	0.66%	575,000	$18,780,000	—	31 Dec 2020	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.64%	557,986	$18,224,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	0.6%	525,262	$17,155,000	—	31 Dec 2020	13F
Rock Springs Capital Management LP	13F	Company	0.58%	508,116	$16,595,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.58%	501,620	$16,383,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.57%	496,400	$16,212,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.54%	471,494	$15,399,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	421,639	$13,771,000	—	31 Dec 2020	13F
Avidity Partners Management LP	13F	Company	0.4%	347,645	$11,354,000	—	31 Dec 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.4%	346,518	$11,317,000	—	31 Dec 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.37%	325,000	$10,615,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.33%	285,596	$9,328,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.32%	282,917	$9,240,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.32%	274,512	$8,966,000	—	31 Dec 2020	13F
Tekla Capital Management LLC	13F	Company	0.31%	273,463	$8,931,000	—	31 Dec 2020	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.31%	271,500	$8,867,000	—	31 Dec 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.3%	264,295	$8,632,000	—	31 Dec 2020	13F
Affinity Asset Advisors, LLC	13F	Company	0.3%	260,000	$8,492,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.3%	259,316	$8,469,260	—	31 Dec 2020	13F
Polar Capital Holdings Plc	13F	Company	0.28%	241,000	$7,871,000	—	31 Dec 2020	13F

Institutional Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q1 2021

As of 31 Mar 2021, Kura Oncology, Inc. - Common Stock (KURA) was held by 162 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,584,982 shares. The largest 10 holders included FMR LLC, BlackRock Inc., Avoro Capital Advisors LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, Holocene Advisors, LP, Foresite Capital Management IV, LLC, and Invesco Ltd.. This page lists 162 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

192

Q1 2021 holders

162

Holder diff

-30

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.